3631 results for «916»
3631 results
Primary PCI in challenging anatomy
19 May 2026 – From EuroPCR 2026
Focusing on primary PCI in challenging coronary anatomies, this session covers intracoronary thrombolysis for ectasia, imaging-guided no-stent strategies in vein graft occlusions, and management of coronary aneurysms presenting with acute coronary syndromes, highlighting tailored interventional approaches.
Rescue PCI for acute or unusual left main lesions
19 May 2026 – From EuroPCR 2026
This session explores rescue PCI techniques for acute and unusual left main coronary lesions, highlighting complex cases such as left main compression syndrome in pulmonary hypertension, and challenging strategies in acute coronary syndromes with left main occlusion and anatomical variations.
Managing life-threatening TAVI complications
19 May 2026 – From EuroPCR 2026
Manage life-threatening complications in TAVI procedures with a structured algorithm for identification and resolution. This session shares expert tips for handling specific severe complications and reviews best practices aimed at complication avoidance to enhance patient safety and procedural success.
Managing difficult TAVI scenarios
19 May 2026 – From EuroPCR 2026
Focused on complex TAVI cases, this session reviews guideline recommendations for TAVI in younger patients, strategies for managing concomitant coronary artery disease, and considerations for treating asymptomatic severe aortic stenosis. Real-world cases illustrate clinical decision-making and outcomes.
All we need to know about vulnerable plaque
19 May 2026 – From EuroPCR 2026
Understand the critical importance of vulnerable plaque identification and management. This session covers optimal strategies for detecting vulnerable plaques, their prognostic implications, and evidence-based treatment approaches illustrated through detailed case presentations.
Improving interventional care and occupational safety
19 May 2026 – From EuroPCR 2026
This session addresses advancements in interventional cardiology care quality and occupational safety. Key topics include patient-centered care perspectives, optimized catheterization lab scheduling, the impact of procedural volumes on outcomes, and innovations in radiation protection technologies.
Beyond valves: expanding the structural toolbox
19 May 2026 – From EuroPCR 2026
This session expands the scope of structural heart interventions beyond valve therapies. It covers embolic protection in high-risk intracardiac procedures, outcomes of paravalvular leak closures, novel aortic root stent-graft research, cerebral ischemia predictors after TEVAR, and transcatheter ASD closure techniques.
Next generation TAVI procedural planning
19 May 2026 – From EuroPCR 2026
Explore the forefront of TAVI procedural planning, featuring innovations such as valve-in-valve techniques for sutureless valves, integration of artificial intelligence in heart team decisions, and advanced imaging-guided access methods. The session also examines clinical outcomes related to bicuspid anatomy and prosthesis-patient mismatch, providing a comprehensive view...
Selecting PCI devices in specific scenarios
19 May 2026 – From EuroPCR 2026
This session addresses device selection strategies tailored to specific interventional cardiology scenarios. It covers innovative approaches such as coronary laser use in difficult lesions, intravascular imaging-guided treatments for in-stent restenosis, and physiological assessment post-magnesium scaffold resorption, supported by real-world data and emerging machine learning applications.
New evidence in the treatment of calcified lesions
19 May 2026 – From EuroPCR 2026
This session presents the latest evidence on treating calcified coronary lesions, comparing intravascular lithotripsy, cutting balloons, rotational and orbital atherectomy. It includes clinical trial data on efficacy, safety, and impact on coronary microvascular function, providing a robust foundation for evidence-based decision-making in calcified lesion management.
TAVI procedural complications - Part 1: VSD, valve embolisation, and more
19 May 2026 – From EuroPCR 2026
This session focuses on the complex complications that can arise during TAVI procedures, such as ventricular septal defects, valve embolisation, and other critical events. Through detailed case analyses, it offers strategies for recognition, prevention, and management to improve patient safety and outcomes.
How to prevent and manage complex and complicated LAA closure cases?
19 May 2026 – From EuroPCR 2026
Designed to enhance procedural success in transcatheter left atrial appendage closure, this session addresses identification of complex anatomies, management of intraprocedural challenges, and strategies to prevent and handle complications, illustrated by practical case examples and expert evaluations.
How should I treat a patient with a calcified mitral anatomy?
19 May 2026 – From EuroPCR 2026
This session explores the management of patients with calcified mitral anatomy, from advanced imaging assessment to intervention planning. It evaluates the suitability of mitral annular calcification for transcatheter edge-to-edge repair (TEER) and discusses alternative therapeutic options for patients ineligible for TEER.
Angiography-based physiology in clinical practice
19 May 2026 – From EuroPCR 2026
Investigate the clinical application of angiography-based physiology in coronary artery disease management. This session covers quantitative flow ratio (QFR) guided PCI strategies, risk stratification in chronic coronary syndrome, and prognostic value of angiography-derived indices, offering a wire-free diagnostic approach supported by recent trial data.
How can we improve the management of aortic stenosis in 2026?
19 May 2026 – From EuroPCR 2026
As aortic stenosis management continues to evolve, this EuroPCR 2026 session looks ahead to the challenges and opportunities shaping clinical practice in 2026. From implementing the latest guidelines in daily care to refining the timing of intervention, the discussion focuses on how earlier identification and treatment...
From referral to discharge: European consensus on the TAVI care pathway
19 May 2026 – From EuroPCR 2026
Across Europe, TAVI programmes are under increasing pressure from rising demand, capacity limits and referral barriers. This EuroPCR 2026 session presents the European consensus on the TAVI care pathway and explores how data-driven, standardised approaches can optimise the patient journey from referral to discharge.
Bringing together clinicians,...
DCB in contemporary PCI: evidence, technique and physiology-guided decision-making
19 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session explores the evolving role of drug-coated balloons (DCB) in contemporary PCI, highlighting how growing clinical evidence, refined procedural strategies and physiology-guided tools are reshaping everyday practice.
The discussion reviews the latest data supporting DCB use, including long-term outcomes from major registries and trials...
Evolving bifurcation treatment practices: DCB, angio-based FFR and side branch optimisation
19 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session explores the evolving landscape of bifurcation PCI, focusing on drug-coated balloon (DCB) strategies, angio-based fractional flow reserve (FFR) and side branch optimisation. It highlights how new evidence and physiology-guided tools are reshaping decision-making in this complex lesion subset.
Discussions include insights from the...
Artificial intelligence-driven precision therapy for TAVI: progress and practice in China
19 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session explores the integration of artificial intelligence into precision therapy for TAVI in China, highlighting its growing role in procedural planning, optimisation and outcome prediction.
Through case-based discussion, it shows how AI-enabled tools can simulate valve deployment and visualise post-TAVR results, supporting more precise...
When less is better - Differentiated therapies to safely achieve TR 0-1+
19 May 2026 – From EuroPCR 2026
Therapeutic goals in tricuspid regurgitation are evolving, with increasing emphasis on achieving near-complete elimination of regurgitation (TR 0–1+) through differentiated transcatheter strategies.
This EuroPCR 2026 session explores how transcatheter edge-to-edge repair (TEER) and transcatheter tricuspid valve replacement (TTVR) can be used in a complementary way to reach...
